These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium. Revets H; Vandamme P; Van Zeebroeck A; De Boeck K; Struelens MJ; Verhaegen J; Ursi JP; Verschraegen G; Franckx H; Malfroot A; Dab I; Lauwers S Acta Clin Belg; 1996; 51(4):222-30. PubMed ID: 8858887 [TBL] [Abstract][Full Text] [Related]
3. Evidence of transmission of Burkholderia cepacia, Burkholderia multivorans and Burkholderia dolosa among persons with cystic fibrosis. Biddick R; Spilker T; Martin A; LiPuma JJ FEMS Microbiol Lett; 2003 Nov; 228(1):57-62. PubMed ID: 14612237 [TBL] [Abstract][Full Text] [Related]
4. Burkholderia (Pseudomonas) cepacia epidemiology in a cystic fibrosis population: a genome finger-printing study. Cazzola G; Amalfitano G; Tonolli E; Perazzoli C; Piacentini I; Mastella G Acta Paediatr; 1996 May; 85(5):554-7. PubMed ID: 8827098 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of contamination of the dentist and dental surgery environment with Burkholderia (Pseudomonas) cepacia during treatment of children with cystic fibrosis. Pankhurst CL; Harrison VE; Philpott-Howard J Int J Paediatr Dent; 1995 Dec; 5(4):243-7. PubMed ID: 8957838 [TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of Burkholderia cepacia isolates from cystic fibrosis (CF) patients in an Italian CF center. Petrucca A; Cipriani P; Valenti P; Santapaola D; Cimmino C; Scoarughi GL; Santino I; Stefani S; Sessa R; Nicoletti M Res Microbiol; 2003 Sep; 154(7):491-8. PubMed ID: 14499935 [TBL] [Abstract][Full Text] [Related]
7. PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients. McDowell A; Mahenthiralingam E; Moore JE; Dunbar KE; Webb AK; Dodd ME; Martin SL; Millar BC; Scott CJ; Crowe M; Elborn JS J Clin Microbiol; 2001 Dec; 39(12):4247-55. PubMed ID: 11724828 [TBL] [Abstract][Full Text] [Related]
8. Distribution of genes encoding putative transmissibility factors among epidemic and nonepidemic strains of Burkholderia cepacia from cystic fibrosis patients in the United Kingdom. Clode FE; Kaufmann ME; Malnick H; Pitt TL J Clin Microbiol; 2000 May; 38(5):1763-6. PubMed ID: 10790095 [TBL] [Abstract][Full Text] [Related]
9. Comparison of culture and PCR for detection of Burkholderia cepacia in sputum samples of patients with cystic fibrosis. Whitby PW; Dick HL; Campbell PW; Tullis DE; Matlow A; Stull TL J Clin Microbiol; 1998 Jun; 36(6):1642-5. PubMed ID: 9620393 [TBL] [Abstract][Full Text] [Related]
10. Utility of commercial systems for identification of Burkholderia cepacia complex from cystic fibrosis sputum culture. Shelly DB; Spilker T; Gracely EJ; Coenye T; Vandamme P; LiPuma JJ J Clin Microbiol; 2000 Aug; 38(8):3112-5. PubMed ID: 10921992 [TBL] [Abstract][Full Text] [Related]
11. Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates. McMenamin JD; Zaccone TM; Coenye T; Vandamme P; LiPuma JJ Chest; 2000 Jun; 117(6):1661-5. PubMed ID: 10858399 [TBL] [Abstract][Full Text] [Related]
12. Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis. Chen JS; Witzmann KA; Spilker T; Fink RJ; LiPuma JJ J Pediatr; 2001 Nov; 139(5):643-9. PubMed ID: 11713440 [TBL] [Abstract][Full Text] [Related]
13. Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients. Coenye T; LiPuma JJ; Henry D; Hoste B; Vandemeulebroecke K; Gillis M; Speert DP; Vandamme P Int J Syst Evol Microbiol; 2001 Mar; 51(Pt 2):271-9. PubMed ID: 11321071 [TBL] [Abstract][Full Text] [Related]
14. Preferential adherence of cable-piliated burkholderia cepacia to respiratory epithelia of CF knockout mice and human cystic fibrosis lung explants. Sajjan U; Wu Y; Kent G; Forstner J J Med Microbiol; 2000 Oct; 49(10):875-885. PubMed ID: 11023184 [TBL] [Abstract][Full Text] [Related]
15. Field inversion gel electrophoresis on Pseudomonas cepacia strains isolated from cystic fibrosis patients. Amalfitano G; Tonolli E; Favari F; Perazzoli C; Cazzola G; Mastella G; Piacentini I Eur J Epidemiol; 1996 Apr; 12(2):149-53. PubMed ID: 8817193 [TBL] [Abstract][Full Text] [Related]
16. Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward. Döring G; Jansen S; Noll H; Grupp H; Frank F; Botzenhart K; Magdorf K; Wahn U Pediatr Pulmonol; 1996 Feb; 21(2):90-100. PubMed ID: 8882212 [TBL] [Abstract][Full Text] [Related]
17. The environmental risk factors associated with medical and dental equipment in the transmission of Burkholderia (Pseudomonas) cepacia in cystic fibrosis patients. Pankhurst CL; Philpott-Howard J J Hosp Infect; 1996 Apr; 32(4):249-55. PubMed ID: 8744509 [TBL] [Abstract][Full Text] [Related]
18. Is Burkholderia (Pseudomonas) cepacia disseminated from cystic fibrosis patients during physiotherapy? Ensor E; Humphreys H; Peckham D; Webster C; Knox AJ J Hosp Infect; 1996 Jan; 32(1):9-15. PubMed ID: 8904368 [TBL] [Abstract][Full Text] [Related]
19. PCR ribotyping and endonuclease subtyping in the epidemiology of Burkholderia cepacia infection. Shreve MR; Johnson SJ; Milla CE; Wielinski CL; Regelmann WE Am J Respir Crit Care Med; 1997 Mar; 155(3):984-9. PubMed ID: 9117036 [TBL] [Abstract][Full Text] [Related]
20. Transmission and prevalence of Burkholderia cepacia in Welsh cystic fibrosis patients. Millar-Jones L; Ryley HC; Paull A; Goodchild MC Respir Med; 1998 Feb; 92(2):178-83. PubMed ID: 9616509 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]